Diabetes news 2008
|
|
|
Diabetes monitoring test supplies have improved dramatically in the last five years. Users are benefit from the smaller amount of blood typically required for the diabetes testing strips, which also means less pain and discomfort. 2008
|
Experts call for an uncompromising management of diabetes
Modern medical technology such as insulin pumps and blood glucose meters are helping people with diabetes live a life without sacrifices. Bayer HealthCare Diabetes Cares innovations have likewise changed the face of diabetes management. Ever since the first portable blood glucose meter was introduced in 1969, each new generation has brought further benefits for people living with diabetes, including blood glucose meters with memories, computer interfaces, telephone link-up capability, capillary draw biosensors and multisite lancing. In recent years, Bayer HealthCare Diabetes Care has developed innovative No Coding technology. Bayer introduced the Contour, a 5-second single test meter, and Breeze 2, a 5-second multi-test disc meter, both with No Coding technology. The latest innovations are Contour Link, a meter that communicates
www.prdomain.com
Experts call for an uncompromising management of diabetes - Experts call for an uncompromising management of diabetes
Whereas "Type 1 Diabetes is currently diagnosed with a causal plasma glucose concentration of greater than or equal to 200 mg/dl with symptoms of diabetes (frequent urination, excessive thirst, and unexplained weight loss) OR a fasting plasma glucose of greater than or equal to 126. (American Diabetes Association: Clinical Practice Recommendations 2004, Page S9)" and "If further testing is needed to verify a type 1 diabetes diagnosis, testing for markers of immune destruction of beta cells in the pancreas include islet cell autoantibodies, autoantibodies to glutamic acid decarboxylase and autoantibodies to the tyrosine phosphatases. (American Diabetes Association: Clinical Practice Recommendation 2004, Page S6) As these tests are extremely expensive, they are not done on a routine basis and are rarely covered by third party
www.ireport.com
To: U. S. Congress and All State Legislatures It is very difficult to cure diabetes when insulin dependent diabetic children wrongly believe that they have type 1 diabetes, when in reality they have - Situation_room mike_huckabee
These data from a validated animal model support our belief that Haptoglobin testing may help physicians tailor optimal therapy for patients with diabetes who may be at risk for cardiovascular events. The transport of cholesterol out of atherosclerotic plaque may be an important mechanism of stroke and heart attack prevention. Characterizing the functional impairment of HDL may help us understand how to intervene in Hp2-2 diabetic patients," said Noah Berkowitz, M. D. , Ph. D. , President and Chief Executive Officer of Synvista Therapeutics, which is developing a diagnostic product to identify Haptoglobin types. "As with previous studies of diabetic patients exhibiting markedly elevated cardiovascular risk, we believe that these findings support the notion of testing for Haptoglobin and treating the appropriate diabetic patients
www.foxbusiness.com
- NJ Synvista New Data
Its been 55 years since Watson and Crick defined the structure of DNA. Today, DNA is defining us. Most of the 1,100 genetic tests on the market are for rare single-gene diseases, like cystic fibrosis. But now, DNA-testing companies say they can scan our genomes and tell us our potential risk for diabetes, Alzheimers and other common chronic conditions. Our DNA, once a mystery, is suddenly a commodity, and some two dozen businesses are competing for it in cyberspace. In January, another new company, 23andMe, handed out 1,000 free tests at the World Economic Forum in Davos, then boasted on its blog, The Spittoon, that "scholars, celebs and politicos swarmed" its booth. Featured photos: Naomi Campbell showing off her test kit, New York Times columnist Thomas Friedman spitting into his.
www.healthnewsdigest.com
Should also opt for the more detailed VAP Test. "The VAP cholesterol test allows a detailed analysis of all lipid parameters to obtain an accurate and predictive risk for CVD," said Richard Fowler, M. D. , of the Arizona Center for Internal Medicine. The VAP Test is the first cholesterol test to identify markers for Metabolic Syndrome, a precursor for diabetes. The VAP Test directly and accurately measures fifteen separate components of blood cholesterol compared to just three in a standard cholesterol test. This more comprehensive test has been shown to identify over twice the number of patients with lipid abnormalities than the standard lipid panel (cholesterol and triglyceride test). Risks of both heart disease and diabetes can be reduced with the right preventive treatments, which is why more accurate diagnosis is
www.prnewswire.com
Two findings contrast the varying degree to which this pre-diabetes group is serious about preventing or delaying a diabetes diagnosis," said David Jacobson, senior vice president of GfK Market Measures Roper Global Diabetes Group. "On one hand, nearly a quarter of patients dont take any steps to treat their pre-diabetic condition, representing a market segment that, given the right messaging, might in time be swayed to adopt novel treatment therapies. Conversely, we are encouraged by the proactive behavior we discovered on the part of other patients. Nearly twenty percent of all pre-diabetes patients report having been recommended to test for sugar, and more than 10 percent of all pre-diabetes patients report actually testing - with more than half of them testing once or more a week. "
www.centredaily.com
There is a very large market for early detection technology enabling personalized preventive efforts in diabetes and other chronic diseases. It is estimated that up to 7 pct. of the population, or nearly 21 million people, have diabetes, with more than six million of those currently undiagnosed. Further, the number of individuals at risk for diabetes is estimated to be greater than double the number of those with diabetes. Tethys Diabetes PreDxTM involves a simple to administer blood test, which fits easily into current clinical practice and provides clinically important, personalized risk information - while matching or outperforming traditional clinical risk scores and measures of glucose dysregulation or insulin resistance.
www.pehub.com
Private Equity Hub (peHub) is an interactive forum for the private equity community, which includes venture capitalists, buyouts professionals, attorneys, bankers, entrepreneurs, MBA candidates studying PE, and assorted hangers-on. Its mission is simple: To help you do your job better, by feeding your head with news and views from/about your peers.
In addition, the National Glycohemoglobin Standardization Program (NGSP) has awarded Level I Laboratory Certification to the Quest Diagnostics laboratory in Gurgaon. Level I Laboratory Certification, which is recommended by NGSP for laboratories conducting diabetes-related clinical trials, indicates that a facilitys testing fulfills NGSPs rigorous standards for delivering accurate hemoglobin A1c (HbA1c) testing for diabetes. The Quest Diagnostics lab is one of only five laboratories in India to be certified by the international program. The prevalence of type 2 diabetes in India is expected to grow more rapidly than in any developed or developing nation, climbing from 28 million patients in 2007 to more than 60 million by 2017.
www.tradingmarkets.com
TradingMarkets News for DGX - QUEST DIAGNOSTICS LABORATORY ACCREDITED IN INDIA - DGX
Childrens Hospital is taking part in Type 1 Diabetes TrialNet, a worldwide consortium of research centers dedicated to delaying or preventing the onset of type 1 diabetes in children and adults. Under TrialNet, centers perform blood tests on children and adults who are at higher risk for type 1 diabetes because a close family member (first- or second-degree) has the disease. If the blood test detects autoantibodies to diabetes that may appear years before type 1 diabetes develops, the patient may enter a study of a new medical intervention that uses oral insulin. A preliminary study indicated that oral insulin may delay or prevent type 1 diabetes among some people found to be at risk of the disease. Childrens Hospital is among 150 medical centers on three continents participating in Type 1 Diabetes TrialNet, sponsored by the
www.newswise.com
The test is a measure of long-term glucose control, but doctors dont typically use it to screen for or diagnose the disease, " says Christopher Saudek, M. D. , professor of endocrinology and metabolism at the Johns Hopkins University School of Medicine and director of the Johns Hopkins Comprehensive Diabetes Center. "Theres reason to believe it could help identify many of the estimated six million people in the U. S. who have diabetes but dont know it," he adds. The current screening and diagnostic tests measure only the amount of sugar present at the moment that blood sample is taken. Consequently, Saudek says, these tests are accurate only if patients fast for at least 10 hours before the test because glucose concentrations can vary greatly depending on a persons recent meals.
www.sciencedaily.com
A blood test currently used as the gold standard for monitoring people already under care for diabetes may have far wider use in identifying millions with undetected diabetes. - Diabetes; Diseases and Conditions; Chronic Illness; Hormone Disorders; Todays Healthcare; Hypertension
